Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 51% ± 13% | |
lung | 18 studies | 50% ± 16% | |
intestine | 14 studies | 38% ± 21% | |
brain | 12 studies | 35% ± 13% | |
kidney | 9 studies | 66% ± 13% | |
eye | 8 studies | 46% ± 14% | |
bone marrow | 7 studies | 36% ± 16% | |
lymph node | 7 studies | 60% ± 8% | |
uterus | 6 studies | 47% ± 23% | |
liver | 6 studies | 38% ± 15% | |
heart | 5 studies | 30% ± 14% | |
placenta | 4 studies | 52% ± 21% | |
pancreas | 4 studies | 25% ± 9% | |
prostate | 4 studies | 39% ± 11% | |
breast | 4 studies | 44% ± 9% | |
ovary | 3 studies | 45% ± 15% | |
adrenal gland | 3 studies | 51% ± 11% | |
esophagus | 3 studies | 41% ± 20% | |
skin | 3 studies | 25% ± 7% | |
thymus | 3 studies | 75% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 29592.34 | 2641 / 2642 | 100% | 27.59 | 704 / 705 |
adrenal gland | 100% | 24445.17 | 258 / 258 | 98% | 14.66 | 226 / 230 |
kidney | 100% | 49515.37 | 89 / 89 | 98% | 21.92 | 885 / 901 |
ovary | 100% | 20939.92 | 180 / 180 | 98% | 25.10 | 422 / 430 |
bladder | 100% | 19628.33 | 21 / 21 | 95% | 20.53 | 480 / 504 |
thymus | 100% | 14704.94 | 651 / 653 | 94% | 13.34 | 569 / 605 |
lung | 99% | 13605.65 | 572 / 578 | 91% | 15.51 | 1047 / 1155 |
uterus | 100% | 14495.06 | 170 / 170 | 87% | 16.62 | 399 / 459 |
intestine | 95% | 14864.34 | 922 / 966 | 86% | 17.01 | 451 / 527 |
esophagus | 96% | 15176.88 | 1384 / 1445 | 85% | 16.66 | 155 / 183 |
stomach | 100% | 20746.60 | 359 / 359 | 80% | 14.90 | 230 / 286 |
pancreas | 99% | 12485.79 | 324 / 328 | 67% | 6.32 | 120 / 178 |
skin | 62% | 12656.08 | 1128 / 1809 | 98% | 18.81 | 461 / 472 |
prostate | 100% | 12237.67 | 244 / 245 | 58% | 5.43 | 292 / 502 |
breast | 100% | 18849.05 | 458 / 459 | 44% | 5.85 | 492 / 1118 |
adipose | 100% | 24903.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 24.69 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.76 | 29 / 29 |
spleen | 100% | 10632.43 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.73 | 1 / 1 |
blood vessel | 100% | 15033.19 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 54787.38 | 840 / 861 | 0% | 0 | 0 / 0 |
muscle | 84% | 9461.23 | 675 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 10.72 | 37 / 45 |
peripheral blood | 64% | 16252.03 | 593 / 929 | 0% | 0 | 0 / 0 |
liver | 1% | 89.30 | 2 / 226 | 10% | 1.14 | 39 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006089 | Biological process | lactate metabolic process |
GO_0019674 | Biological process | NAD metabolic process |
GO_0006090 | Biological process | pyruvate metabolic process |
GO_1990204 | Cellular component | oxidoreductase complex |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0045121 | Cellular component | membrane raft |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0019900 | Molecular function | kinase binding |
GO_0051287 | Molecular function | NAD binding |
GO_0004459 | Molecular function | L-lactate dehydrogenase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LDHB |
Protein name | L-lactate dehydrogenase B chain L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46) L-lactate dehydrogenase (EC 1.1.1.27) |
Synonyms | hCG_24788 HEL-S-281 |
Description | FUNCTION: Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+). . FUNCTION: Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+). . FUNCTION: Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+). . FUNCTION: Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+). . FUNCTION: Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+). . FUNCTION: Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+). . |
Accessions | Q5U077 F5H793 P07195 A0A5F9ZHM4 ENST00000673047.2 ENST00000350669.5 ENST00000396076.5 ENST00000396075.5 ENST00000539782.1 C9J7H8 ENST00000450584.5 A8MW50 |